GP0034B CLL and MCL study in the US

Global Patients, in partnership with Modus Outcomes, a health research consulting company, is looking to interview adults living with chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma. Interviews will be conducted over the phone and will take approximately 60-90 minutes. The purpose of this interview is to understand:

  • the symptoms you experience;
  • how those symptoms impact your day-to-day life; and
  • your thoughts about questionnaires used to assess aspects of your condition.

Your feedback will be used to help scientist better understand your condition and measure the progress of different treatments used within drug trials. You will receive up to $188 in compensation for your time participating in activities during one wave of the study, or up to $376 if you participate in wave 1 and wave 2 of the study.  

If you are interested in participating, please contact to determine your eligibility. This study has been reviewed and approved by Copernicus Group Independent Review Board

Join this Study
Are you already a member of Global Patients?

Share this Study!
Share on Facebook
Tweet about this on Twitter
Share on LinkedIn